Mastercard stock steadies after Washington jolt as Jan. 29 earnings loom

Mastercard stock steadies after Washington jolt as Jan. 29 earnings loom

New York, January 14, 2026, 18:17 EST — After-hours

  • Mastercard shares ended the day up 0.6%, then slipped roughly 0.2% in after-hours trading.
  • Traders are grappling with new political pressure on credit-card fees and payment-network regulations.
  • Mastercard will release its fourth-quarter earnings on Jan. 29.

Shares of Mastercard Inc slipped in after-hours trading Wednesday, despite ending the regular session on a positive note. This comes after a week of policy-driven declines in card and payments stocks. The stock closed at $547.99 and was last seen at $546.82 after hours. (Yahoo Finance)

Investors are now grappling with fresh U.S. political risks tied to credit cards—specifically, proposed caps on consumer interest rates and renewed scrutiny of Visa and Mastercard’s control over transaction routing. Analysts at William Blair urge long-term investors to “accumulate Visa, Mastercard, and American Express shares amid uncertainty-driven weakness.” However, they caution that valuations could still slide 10% to 20% in the near term. (Investopedia)

Senators Dick Durbin and Roger Marshall brought back the Credit Card Competition Act on Tuesday, according to Payments Dive. The bill would force major banks—those with $100 billion or more in assets—to offer merchants at least one routing choice apart from Visa or Mastercard. The goal: tackle interchange fees, the charges merchants face when customers pay by credit card. (Payments Dive)

Mastercard shares ended Tuesday at $544.99, per the company’s investor relations page, as the proposed measures sent ripples through payments and banking stocks. (Mastercard Investor Relations)

Separately, Compass Point’s Dominick Gabriele bumped Mastercard from “neutral” to “buy,” raising his price target to $735, StreetInsider reports. (Streetinsider)

This week, Mastercard pushed its services angle further by teaming up with Agoda, owned by Booking Holdings, to integrate travel options into Mastercard’s Global Redemption Suite for loyalty programs. Agoda’s Chief Commercial Officer Damien Pfirsch highlighted that “banks gain a simple, scalable way to modernize loyalty and drive deeper engagement.” (Mastercard)

Investors got fresh data to digest: U.S. retail and food services sales climbed 0.6% in November compared to October. Producer prices for final demand also nudged up 0.2%. These figures could influence the interest rate environment that impacts consumer spending. (Census)

The politics remain the wildcard. While Visa and Mastercard don’t pocket interest income—that goes to banks—a sweeping crackdown could reshape how issuers promote cards, finance rewards, or direct transaction flow. The routing bill, meanwhile, hits the fee structure head-on.

Mastercard plans to report its fourth-quarter and full-year 2025 results on Thursday, Jan. 29, followed by a conference call at 9:00 a.m. Eastern. Investors will zero in on U.S. volume trends, cross-border activity, and the company’s take on recent regulatory developments. (Mastercard Investor Relations)

Stock Market Today

  • Teladoc Health Valuation Signals Undervalued Despite Recent Volatility
    January 14, 2026, 6:42 PM EST. Teladoc Health trades around $6.61 as recent swings weigh on the stock. A 1-day return of 5.44% and a 7-day gain of 12.68% come after a year-to-date rise of 6.24%. Over the past year, the 1-year TSR stands at 29.30% and the 5-year TSR at 97.32%, reflecting shifting investor sentiment about growth and risk. Analysts' consensus targets place fair value near $9.125, with a range from $7.00 to $12.00; the gap implies potential upside if profitability improves. The upside hinges on gains in enrollment momentum and margin expansion, while risks include BetterHelp's lower-margin insurance revenue and increased competition in chronic care. The narrative suggests a lower earnings multiple versus peers, but valuation could illuminate the path forward.
Robinhood stock slips after hours as Senate crypto bill and bitcoin rebound reshape the setup
Previous Story

Robinhood stock slips after hours as Senate crypto bill and bitcoin rebound reshape the setup

Eli Lilly stock dips after hours as FDA seeks label change for Zepbound, traders eye obesity pill push
Next Story

Eli Lilly stock dips after hours as FDA seeks label change for Zepbound, traders eye obesity pill push

Go toTop